Sr. Director - HEMAR, Americas Region Head

Overview

Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams everywhere. For 70 years, our team has driven meaningful innovations in kidney care. As we build on our legacy, we are deepening our commitment to elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies.

Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients— that is what Vantive aspires to deliver.

We believe Vantive will not only build our leadership in the kidney care space, it will also offer meaningful work to those who join us. At Vantive, you will become part of a community of people who are focused, courageous and don’t settle for the mediocre. Each of us is driven to help improve patients’ lives worldwide. Join us in advancing our mission to extend lives and expand possibilities.

The Sr. Director - HEMAR, Americas Region Head role has a dual responsibility across the Chronic and Acute portfolios BUs:

• Responsible for reimbursement and policy strategies across the Americas region
• Direct line management of HEMAR leads in the Americas region
• Leadership of the HEMAR strategy for the Americas region by coordinating with the local marketing and sales organizations, driving for example economic evidence dissemination and value strategies with Payers and Providers
• Input into strategic and business planning activities of both Chronic and Acute organizations
• Represents the voice of non‑clinical stakeholders in the Americas Region, establishes the access and evidence requirements for successful new product development and introduction, collaborates closely with R&D, Upstream Marketing and Medical Affairs

• Lead HEMAR Strategy for the Americas. (including policy, reimbursement and HTA)
• Direct line management of HEMAR team in the Americas region
• Responsibility for economic evidence dissemination to payers and providers and building capability across the commercial (evidence‑based selling) and Medical Affairs organization
• Strategic partner for New Product Development (R&D) value proposition: non‑clinical stakeholder dimension, value‑based pricing, target product profile (TPP)
• Lead economic evidence generation projects in the region (Outcomes Research)

• MARKET ACCESS ASSESSMENT & STRATEGY – Leader
• Understand the healthcare environment (including reimbursement, policy), the external marketplace and market access requirements in North America as well as other key geographies in the Americas region, with proven experience in Brazil and Mexico
• Develop strategies for market access and adoption in the region
• Provide inputs to relevant new product development, life‑cycle optimization, licensing & acquisition
• Support execution of commercial strategies with global/regional/country commercial partners
• Understand commercial financial information related to the business, KPIs and financial forecasting metrics and trends impacted by market access, funding and reimbursement
• STRATEGIC THINKING and INNOVATION
  - Expert
• Apply HEMAR perspectives and knowledge to current and future portfolio and solution planning to deliver mid and long‑term business success.
• Working with cross‑functional teams to develop a clear set of goals and plans.
• Understand and shape innovation strategy to optimize value, access and adoption
• Assess, shape and plan for quantifying potential value propositions and TPPs for NPD to optimize market access and adoption
• Integration of value‑based thinking and market access requirements into strategies, TPPs and Vantive Evidence Generation Strategies

• Proven experience in North America and key geographies in the region including Mexico and Brazil:
  Health Economics and Outcomes Research, Health Technology Assessment, Market Access, Real World Evidence, Reimbursement
• International experience, leading various markets or regions is highly preferred. Has worked or supported in at least two different markets, one of them being NA
• Min…